Interfaces between COVID-19 and immunotherapy in cancer patients
Q&A and live discussion
Date
12 Dec 2020Session
Interfaces between COVID-19 and immunotherapy in cancer patientsPresenters
All SpeakersAuthors
A. SpeakersAuthor affiliations
- /US
Resources
Resources from the same session
Checkpoint blockade in the era of COVID-19: Pros and cons
Presenter: Emanuela Romano
Session: Interfaces between COVID-19 and immunotherapy in cancer patients
Resources:
Slides
Webcast
Cancer treatment in COVID-19 patients
Presenter: Marina Garassino
Session: Interfaces between COVID-19 and immunotherapy in cancer patients
Resources:
Slides
Webcast
Is there a role for jak1/2 inhibitors in patients with severe COVID-19?
Presenter: Stefan Constaniescu
Session: Interfaces between COVID-19 and immunotherapy in cancer patients
Resources:
Slides
Webcast
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients
Presenter: David Pinato
Session: Interfaces between COVID-19 and immunotherapy in cancer patients
Resources:
Slides
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.